Post-market review of chronic obstructive pulmonary disease medicines – final report released

30 January 2018 - The final report and outcomes of the post-market review of chronic obstructive pulmonary disease medicines is now ...

Read more →

Rare disease medicine changes offer clarity

29 January 2018 - Proposed changes to the provision of medicines for rare diseases should bring greater certainty for people ...

Read more →

Medicines Australia welcomes LSDP review outcomes

28 January 2018 - Medicines Australia welcomes the Government’s announcement of an outcome from the post-market review of the Life ...

Read more →

Review of the Life Saving Drugs Program - final report and Government response

28 January 2018 - After nearly 4 years and 3 health ministers, the final report and Government's response to the ...

Read more →

Draft report for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis

18 January 2018 - The draft report for the post-market review of the use of biologics in the treatment of severe ...

Read more →

PBS expenditure and prescriptions report - 2016-17

20 December 2017 - The PBS expenditure and prescriptions report for 2016-17 is now available. ...

Read more →

Post-market review of ezetimibe - final report

20 December 2017 - The final report for the post-market review of ezetimibe and PBAC recommendations for the post-market review of ...

Read more →

Report urges transparency in health system

19 December 2017 - Individual doctors' fees should be available in a searchable database, according to a recommendation of a Senate ...

Read more →

CHF supports Healthy people, healthy systems

18 December 2017 - The Consumers Health Forum welcomes the Australian Healthcare and Hospitals Association’s blueprint for a national health ...

Read more →

Not so anonymous: Medicare data can be used to identify individual patients, researchers say

18 December 2017 - Researchers say they can identify individuals in government healthcare data that was supposed to be anonymous, ...

Read more →

Recommendations made by the PBAC - November 2017

15 December 2017 - The recommendations from the November 2017 PBAC meeting are now available. ...

Read more →

Report on the collection of under co-payment data 2016-17

14 December 2017 - From 1 July 2016 to 30 June 2017, approximately 85 million under co-payment prescriptions were supplied ...

Read more →

Public summary documents - July 2017 PBAC meeting

27 October 2017 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the July 2017 PBAC ...

Read more →

New fact sheets - infliximab biosimilars

22 September 2017 - Fact sheets about infliximab biosimilars for consumers and health care professionals are now available on the Department ...

Read more →

Confirmed 1 October 2017 prices - 2017 October cycle

14 September 2017 - Confirmed 1 October 2017 prices resulting from the 2017 October cycle of price disclosure have now been ...

Read more →